Allogenic mesenchymal stem cells therapy(NeoProgen)

N/A

Report date: 2023/01/12 15:31:53

Base Information

Drug NameAllogenic mesenchymal stem cells therapy(NeoProgen)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsHeart FailureCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland
Inactive CompaniesN/A
Active IndicationsHeart FailureCardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A